Cargando…

Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts

The molecular co-chaperone CDC37 is over-expressed in hepatocellular carcinoma (HCC) cells, where it functions with HSP90 to regulate the activity of protein kinases in multiple oncogenic signaling pathways that contribute towards hepatocarcinogenesis. Disruption of these signaling pathways via inhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Wei, Wu, Song, Wang, Xiaolin, Sun, Chris Kin-Wai, Yang, Xiaoyang, Yan, Xinrui, Chua, Mei-Sze, So, Samuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170594/ https://www.ncbi.nlm.nih.gov/pubmed/25051375

Ejemplares similares

Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells
por: Ma, Li, et al.
Publicado: (2015)

Molecular Imaging of Hepatocellular Carcinoma Xenografts with Epidermal Growth Factor Receptor Targeted Affibody Probes
por: Zhao, Ping, et al.
Publicado: (2013)

A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts
por: Natarajan, Arutselvan, et al.
Publicado: (2021)

Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells
por: Du, Shihao, et al.
Publicado: (2020)

Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo
por: Yan, Xinrui, et al.
Publicado: (2008)

Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
por: Wei, Wei, et al.
Publicado: (2011)

Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF
por: Song, Mingxia, et al.
Publicado: (2023)

NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation
por: Lu, Wen-Jing, et al.
Publicado: (2015)

Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition
por: Xu, Shaohua, et al.
Publicado: (2021)

Erlotinib Inhibits Growth of a Patient-Derived Chordoma Xenograft
por: Siu, I-Mei, et al.
Publicado: (2013)

Celastrol Inhibits the Growth of Ovarian Cancer Cells in vitro and in vivo
por: Xu, Li-Na, et al.
Publicado: (2019)

Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
por: Wei, Wei, et al.
Publicado: (2009)

Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol
por: Xiao-pei, Huang, et al.
Publicado: (2018)

Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line
por: Cheung, Phyllis F. Y., et al.
Publicado: (2016)

Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling
por: Lu, Wen-Jing, et al.
Publicado: (2015)

Synthesis and characterisation of celastrol derivatives as potential anticancer agents
por: Zhang, Hong-Jian, et al.
Publicado: (2017)

Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts
por: Zhuo, Jianyong, et al.
Publicado: (2021)

Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model
por: Li, Zhanrong, et al.
Publicado: (2012)

TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis
por: Wang, Shuren, et al.
Publicado: (2016)

Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
por: Jiang, Zhiwu, et al.
Publicado: (2017)

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
por: Wang, Huabo, et al.
Publicado: (2015)

Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy
por: Lee, Hyun-Woo, et al.
Publicado: (2014)

Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient‐Derived Xenograft Models
por: Johnston, Michael Edward, et al.
Publicado: (2021)

SHP2 inhibition improves celastrol-induced growth suppression of colorectal cancer
por: Zhang, Linxi, et al.
Publicado: (2022)

Hepatocellular Carcinoma Growth Is Inhibited by Euphorbia helioscopia L. Extract in Nude Mice Xenografts
por: Cheng, Junsheng, et al.
Publicado: (2015)

Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer
por: Xu, Wei, et al.
Publicado: (2020)

Correction: Systematic identification of celastrol-binding proteins reveals that Shoc2 is inhibited by celastrol
Publicado: (2021)

Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts
por: Lipner, Matthew B., et al.
Publicado: (2016)

Design, Synthesis and Biological Evaluation of C(6)-Modified Celastrol Derivatives as Potential Antitumor Agents
por: Tang, Kaiyong, et al.
Publicado: (2014)

Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma
por: Sun, Hongbo, et al.
Publicado: (2008)

Establishment of hepatocellular carcinoma patient-derived xenografts from image-guided percutaneous biopsies
por: Tischfield, David J., et al.
Publicado: (2019)

Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
por: Blinova, Ekaterina V., et al.
Publicado: (2018)

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma
por: Huynh, Hung, et al.
Publicado: (2009)

Effect of Celastrol on Growth Inhibition of Prostate Cancer Cells through the Regulation of hERG Channel In Vitro
por: Ji, Nan, et al.
Publicado: (2015)

A Celastrol Drug Delivery System Based on PEG Derivatives: The Structural Effects of Nanocarriers
por: Zhang, Yansong, et al.
Publicado: (2023)

Inhibition of IKKβ by celastrol and its analogues – an in silico and in vitro approach
por: Veerappan, Karpagam, et al.
Publicado: (2016)

Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft
por: Hsu, Che-Yuan, et al.
Publicado: (2023)

Patient-derived xenograft models in hepatopancreatobiliary cancer
por: Pan, Binhua, et al.
Publicado: (2022)

Celastrol induces apoptosis in hepatocellular carcinoma cells via targeting ER-stress/UPR
por: Ren, Bo, et al.
Publicado: (2017)

Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma
por: Shanmugam, Muthu K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iuq6epqiqm35fcma83aos93pkv